About Nippon Shinyaku Co., Ltd. (NPNKF) — Dividend Analysis 2026
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. In addition, it researches, develops, and markets drugs in the areas of gynecology, otorhinolaryngology, and orthopedics. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
Is NPNKF a good dividend investment in 2026?
NPNKF offers a 2.27% forward yield with a 50% payout ratio. Strand Safety Score: 100/100 (Very Safe). The 5-year dividend CAGR of 47.7% demonstrates strong, consistent growth that outpaces inflation.
NPNKF DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your NPNKF portfolio grows to $334.5K vs $272.0K without reinvestment. This is the compound interest effect in action.
NPNKF dividend growth history & forecast
NPNKF has grown its dividend by 0% over the last year and 47.7% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 2.27%.
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 NPNKF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NPNKF.
Gross yield
2.27%
Tax rate
15.00%
After-tax yield
1.93%
Real yield (−CPI)
-0.87%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
2.27%
-0.53%
$227 / yr
🇺🇸 US Taxable (15%) ✓
15%
1.93%
-0.87%
$193 / yr
🇺🇸 US Taxable (20%)
20%
1.82%
-0.98%
$182 / yr
🇬🇧 UK ISA
0%
2.27%
-0.53%
$227 / yr
🇬🇧 UK Taxable
8.75%
2.07%
-0.73%
$207 / yr
🇨🇦 TFSA
0%
2.27%
-0.53%
$227 / yr
🇨🇦 CA Taxable
25%
1.70%
-1.10%
$170 / yr
🇦🇺 Super (pension)
15%
1.93%
-0.87%
$193 / yr
🇦🇺 AU Taxable
30%
1.59%
-1.21%
$159 / yr
🇩🇪 DE Taxable
26.375%
1.67%
-1.13%
$167 / yr
🇫🇷 FR Taxable
30%
1.59%
-1.21%
$159 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NPNKF Income Goal & Break-Even
Dividend Break-Even
9yr
Years for dividends to fully repay your NPNKF investment of $32.00/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$34.9K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$32.5K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in NPNKF for:
Shares needed
38,931
Capital required
$1,245,792
Monthly income
$2,000
Based on current dividend of $0.73/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NPNKF Dividend Payment Schedule
NPNKF pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$1.54 / payment
$6.16 / year after tax
100 shares
$15.41 / payment
$61.65 / year after tax
1,000 shares
$154.12 / payment
$616.49 / year after tax
📊 NPNKF vs Healthcare Benchmarks
How NPNKF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▼-0.53% vs sectorBelow avg
NPNKF
2.27%
avg
2.80%
5Y Dividend CAGR▲+40.90% vs sectorBetter
NPNKF
47.70%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
NPNKF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NPNKF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NPNKF Insider Activity
No recent SEC filings reported in the last 90 days.
📅
Next Earnings Report: 2026-05-08(in 37 days)EPS estimate: $0.43
🔬
Financial Health Scores
Altman Z-Score
7.12
✅ Safe Zone — low bankruptcy risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
4/9
⚠️ Moderate fundamentals
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NPNKF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →